EcoDrugPlus

Tyrosine-Protein Kinase Lyn-Like

Ensembl ID : ENSOKIG00005027156
Gene Symbol: LOC109871713
3 Cross references
189 Possible Orthologues:

Tyrosine-Protein Kinase Srk2

Ensembl ID : ENSOKIG00005016132
Gene Symbol: LOC109896981
2 Cross references
188 Possible Orthologues:

Tyrosine-Protein Kinase Receptor Tie-1-Like

Ensembl ID : ENSOKIG00005004729
Gene Symbol: LOC109898150
3 Cross references
200 Possible Orthologues:

Tyrosine-Protein Kinase Receptor Tie-1-Like

Ensembl ID : ENSOKIG00005044563
Gene Symbol: LOC109902868
3 Cross references
199 Possible Orthologues:

Tyrosine-Protein Phosphatase Non-Receptor Type 11

Ensembl ID : ENSOKIG00005002033
Gene Symbol: LOC109892449
3 Cross references
245 Possible Orthologues:

Ubiquitin-Like Protein Fubi

Ensembl ID : ENSOKIG00005006892
Gene Symbol: LOC109882495
2 Cross references
294 Possible Orthologues:

Uncharacterized Loc109873755

Ensembl ID : ENSOKIG00005039669
Gene Symbol: LOC109873755
3 Cross references
20 Possible Orthologues:

Uncharacterized Loc109905429

Ensembl ID : ENSOKIG00005010448
Gene Symbol: LOC109905429
2 Cross references
185 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSOKIG00005013993
Gene Symbol: UTS2R
3 Cross references
97 Possible Orthologues:

Utrophin

Ensembl ID : ENSOKIG00005014362
Gene Symbol: UTRN
1 Cross references
263 Possible Orthologues:

Utrophin-Like

Ensembl ID : ENSOKIG00005019438
Gene Symbol: LOC109900399
2 Cross references
264 Possible Orthologues:

Vascular Endothelial Growth Factor A-A

Ensembl ID : ENSOKIG00005012470
Gene Symbol: LOC109866336
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).